An interventional study of atomizer and rescue medication in Sedation and Analgesia Assessment, sponsored by Oman Medical Speciality Board. Not yet recruiting at 1 site in Oman. Open to participants aged 2 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-09-10.
Sponsored by Oman Medical Speciality Board · Not applicable, Interventional, and Health services research
To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.
Oman Medical Speciality Board is the lead sponsor of 15 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
inclusion criteria:
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
use as compare between two group
Device: atomizer · Drug: rescue medication · Drug: Midazolam · Drug: fentanyl
use as compare to other group
Device: atomizer · Drug: rescue medication · Drug: Dexmedetomidine · Drug: Placabo
use atomizer to provide the medication in procedure sedation
will be used as rescue if the atomizer medication not fully sedated
Intranasal administration for procedural sedation.
Intranasal administration for procedural sedation.
Intranasal administration for procedural sedation.
use atomizer to provide the placebo in procedure sedation
depth of sedtion
using MOAA/S score, Modified Observer's Assessment of Alertness/Sedation Scale , as 0 high score for deep sedation, 5 not in deep sedation
Time frame: 1 year
Start is estimated for Sep 2025; primary completion for Sep 2026, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Midazolam · Fentanyl · Dexmedetomidine
Oman Medical Speciality Board